Dr. Philip Goldberg, MD (he/him) is an Endocrinologist in New haven, CT with over 15 years of experience. What is your opinion of Dr. Philip Goldberg, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Philip Goldberg, MD has received over $472,894 which includes payments from the following companies:
$184,491.09 from Novo Nordisk Inc
$89,452.49 from LILLY USA, LLC
$67,728.65 from AstraZeneca Pharmaceuticals LP
$62,446.02 from Amgen Inc.
$48,982.91 from Boehringer Ingelheim Pharmaceuticals, Inc.
$3,312.64 from sanofi-aventis U.S. LLC
$2,115.86 from E.R. Squibb & Sons, L.L.C.
$1,220.35 from INSULET CORPORATION
$1,196.05 from Janssen Pharmaceuticals, Inc
$981.35 from Shire North American Group Inc
$804.33 from Corcept Therapeutics
$793.70 from Abbott Laboratories
$781.18 from Merck Sharp & Dohme Corporation
$749.37 from Tandem Diabetes Care, Inc.
$686.04 from Gemini Laboratories, LLC
$470.41 from AbbVie, Inc.
$463.37 from Alexion Pharmaceuticals, Inc.
$451.57 from Medtronic MiniMed, Inc.
$443.94 from GlaxoSmithKline, LLC.
$431.16 from Dexcom, Inc.
Payments received by Dr. Philip Goldberg, MD were from the following categories:
$366,534.06 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!